Ann‐Kathrin Bittner

Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy

Lisa König, Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner et al. · OncoImmunology · 2017 · 128 citations · Full text

Extracellular Vesicles, Breast Oncology, Therapy Failure +12

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients

Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann et al. · Human Immunology · 2016 · 82 citations

Vesicular Hla-g, Breast Oncology, Cancer Immunosurveillance +9

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, Lisa König et al. · Breast Cancer Research · 2016 · 78 citations · Full text

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients

Nils Martin Bruckmann, Julian Kirchner, Lale Umutlu et al. · European Radiology · 2021 · 56 citations · Full text

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

Lisa König, Fabian Mairinger, Oliver Hoffmann et al. · BMC Cancer · 2019 · 52 citations · Full text